Aquestive Therapeutics

General Information


We are a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products to address unmet medical needs. We have a late-stage proprietary product pipeline focused on the treatment of diseases of the Central Nervous System, or CNS. We believe that the characteristics of these patient populations and shortcomings of available treatment options create opportunities for the development and commercialization of meaningfully differentiated medicines.

Employees: 195
Founded: 2004
Contact Information
Address 30 Technology Drive, Warren, N.J. 07059, US
Phone Number (908) 941-1900
Web Address
View Prospectus: Aquestive Therapeutics
Financial Information
Market Cap $367.5mil
Revenues $73.9 mil (last 12 months)
Net Income $-3.4 mil (last 12 months)
IPO Profile
Symbol AQST
Exchange NASDAQ
Shares (millions): 4.0
Price range $15.00 - $15.00
Est. $ Volume $60.0 mil
Manager / Joint Managers BMO Capital Markets/ RBC Capital Markets
CO-Managers Wedbush PacGrow/ JMP Securities
Expected To Trade: 7/25/2018
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change